Clinical features and outcome of sporadic serogroup W135 disease Taiwan

BMC Infectious Diseases

Volumn 6, Issue , 2006, Pages

  Wang, Jiun Ling ^a   Liu, Ding Ping ^b   Yen, Jer Jea ^b   Yu, Chia Jung ^b   Liu, Hsi Chen ^b   Lin, Ching Yuang ^c   Chang, Shan Chwen ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b CENTER FOR DISEASE CONTROL   (Taiwan)

^c CHANG JUNG CHRISTIAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BACTEREMIA; BLOOD GROUP TYPING; CEREBROSPINAL FLUID ANALYSIS; CHILD; CLINICAL FEATURE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; EPIDEMIC MENINGITIS; FEMALE; GEOGRAPHIC DISTRIBUTION; HEALTH SURVEY; HUMAN; INFANT; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MORTALITY; NEISSERIA MENINGITIDIS; PNEUMONIA; POPULATION DISTRIBUTION; PREVALENCE; PURPURA; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TAIWAN;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; MENINGOCOCCAL INFECTIONS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEISSERIA MENINGITIDIS, SEROGROUP W-135; TAIWAN;

EID: 32944482694     PISSN: 14712334     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-6-7     Document Type: Article

References (25)

1. Rosenstein NE, Perkins BA, Stephens DS, Lefkowitz L, Cartter ML, Danila R, Cieslak P, Shutt KA, Popovic T, Schuchat A, Harrison LH, Reingold AL: The changing epidemiology of meningococcal disease in the United States, 1992-1996. J Infect Dis 1999, 180:1894-901.
2. Taha MK, Achtman M, Alonso JM, Greenwood B, Ramsay M, Fox A, Gray S, Kaczmarski E: Serogroup W135 meningococcal disease in Hajj pilgrims. Lancet 2000, 356:2159.
3. Lingappa JR, Al-Rabeah AM, Hajjeh R, Mustafa T, Fatani A, Al-Bassam T, Badukhan A, Turkistani A, Makki S, Al-Hamdan N, Al-Jeffri M, Al Mazrou Y, Perkins BA, Popovic T, Mayer LW, Rosenstein NE: Serogroup W-135 meningococcal disease during the Hajj, 2000. Emerg Infect Dis 2003, 9:665-71.
4. Aguilera JF, Perrocheau A, Meffre C, Hahne S, W135 Working Group: Outbreak of serogroup W135 meningococcal disease after the Hajj pilgrimage, Europe, 2000. Emerg Infect Dis 2002, 8:761-7.
5. Dull PM, Abdelwahab J, Sacchi CT, Becker M, Noble CA, Barnett GA, Kaiser RM, Mayer LW, Whitney AM, Schmink S, Ajello GW, Dolan-Livengood J, Stephens DS, Cetron MS, Popovic T, Rosenstein NE: Neisseria meningitidis serogroup W-135 carriage among US travelers to the 2001 Hajj. J Infect Dis 2005, 191:33-9.
6. Wilder-Smith A, Goh KT, Barkham T, Paton NI: Hajj-associated outbreak strain of Neisseria meningitidis serogroup W135: estimates of the attack rate in a defined population and the risk of invasive disease developing in carriers. Clin Infect Dis 2003, 36:679-83.
7. Taha MK, Giorgini D, Ducos-Galand M, Alonso JM: Continuing diversification of Neisseria meningitidis W135 as a primary cause of meningococcal disease after emergence of the serogroup in 2000. J Clin Microbiol 2004, 42:4158-63.
8. Mayer LW, Reeves MW, Al-Hamdan N, Sacchi CT, Taha MK, Ajello GW, Schmink SE, Noble CA, Tondella ML, Whitney AM, Al-Mazrou Y, Al-Jefri M, Mishkhis A, Sabban S, Caugant DA, Lingappa J, Rosenstein NE, Popovic T: Outbreak of W135 meningococcal disease in 2000: not emergence of a new W135 strain but clonal expansion within the electophoretic type-37 complex. J Infect Dis 2002, 185:1596-605.
9. Brandstetter RD, Blair RJ, Roberts RB: Neisseria meningitidis sero-group W 135 disease in adults. JAMA 1981, 246:2060-1.
10. Matsika-Claquin MD, Perrocheau A, Taha MK, Levy-Bruhl D, Renault P, Alonso JM, Desenclos JC: Meningococcal W135 infection epidemics associated with pilgrimage to Mecca in 2000. Presse Med 2001, 30:1529-34.
11. Faye A, Mariani-Kurkdjian P, Taha MK, Angoulvant F, Antonios M, Aubertin G, Soussan V, Bingen E, Bourrillon A: Clinical features and outcome of pediatric Neisseria meningitidis serogroup W135 infection: a report of 5 cases. Clin Infect Dis 2004, 38:1635-7.
12. Vienne P, Ducos-Galand M, Guiyoule A, Pires R, Giorgini D, Taha MK, Alonso JM: The role of particular strains of Neisseria meningitidis in meningococcal arthritis, pericarditis, and pneumonia. Clin Infect Dis 2003, 37:1639-42.
13. Apicella M: Extrameningeal complications of Neisseria meningitidis serogroup W135 infection. Clin Infect Dis 2004, 38:1638-9.
14. Hsueh PR, Teng LJ, Lin TY, Chen KT, Hsu HM, Twu SJ, Ho SW, Luh KT: Re-emergence of meningococcal disease in Taiwan: circulation of domestic clones of Neisseria meningitidis in the 2001 outbreak. Epidemial Infect 2004, 132:637-45.
15. Knapp JS, Rice RJ:. In Neisseria and Branhamella. Manual of Clinical Microbiology 6th edition. Edited by: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH. American Society for Microbiology, Washington D. C, ASM; 1995.
16. Racoosin JA, Whitney CG, Conover CS, Diaz PS: Serogroup Y meningococcal disease in Chicago, 1991-1997. JAMA 1998, 280:2094-8.
17. Ramsay M, Kaczmarski E, Rush M, Mallard R, Farrington P, White J: Changing patterns of case ascertainment and trends in meningococcal disease in England and Wales. Commun Dis Rep CDR Rev 1997, 7:R49-54.
18. Matsika-Claquin MD, Perrocheau A, Taha MK, Levy-Bruhl D, Alonso JM, Desenclos JC: Meningococcal W135 infection epidemics associated with pilgrimage to Mecca in 2000. Presse Med 2001, 30:1529-34. (In French)
19. Chiou CS, Liao JC, Liao TL, Li CC, Chou CY, Chang HL, Yao SM, Lee YS: Molecular epidemiology and emergence of worldwide epidemic clones of Neisseria meningitidis in Taiwan. BMC Infect Dis 2006, 6:25. accept
20. Al-Mazrou YY, Al-Jeffri MH, Abdalla MN, Elgizouli SA, Mishskas AA: Changes in epidemiological pattern of meningococcal disease in Saudi Arabia. Does it constitute a new challenge for prevention and control? Saudi Med J 2004, 25:1410-3.
21. Fijen CA, Kuijper EJ, Hannema AJ, Sjoholm AG, van Putten JP: Complement deficiencies in patients over ten years old with meningococcal disease dueto uncommon serogroups. Lancet 1989, 2:585-8.
22. Castellanos-Ortega A, Delgado-Rodriguez M: Comparison of the performance of two general and three specific scoring systems for meningococcal septic shock in children. Crit Care Med 2000, 28:2967-73.
23. Thomson AP, Sills JA, Hart CA: Validation of the Glasgow Meningococcal Septicemia Prognostic Score: a 10-year retrospective survey. Crit Care Med 1991, 19:26-30.
24. Barquet N, Domingo P, Cayla JA, Gonzalez J, Rodrigo C, Fernandez-Viladrich P, Moraga-Llop FA, Marco F, Vazquez J, Saez-Nieto JA, Casal J, Canela J, Foz M: Prognostic factors in meningococcal disease. Development of a bedside predictive model and scoring system. Barcelona Meningococcal Disease Surveillance Group. JAMA 1997, 278:491-6.
25. van Deuren M, Brandtzaeg P, van der Meer JW: Update on meningococcal disease with emphasis on pathogenesis and clinical management. Clin Microbiol Rev 2000, 13:144-66.